Clinical protocol: Phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer.

Abstract

Most patients with chronic wounds fail to heal in a reasonable period of time. Despite considerable advances in elucidating the molecular basis of wound repair, attempts at developing new therapies have been disappointing. In fact, in the few studies where cytokine growth factors have been efficacious, their effect has been dramatically less than would have… (More)

Topics

Cite this paper

@article{Margolis2000ClinicalPP, title={Clinical protocol: Phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer.}, author={David J. Margolis and Timothy M. Crombleholme and Marc Herlyn}, journal={Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society}, year={2000}, volume={8 6}, pages={480-93} }